Featured Research

from universities, journals, and other organizations

Dendritic Cell Immunotherapy May Provide Cancer Patients With A Vaccine To Combat Malignant Brain Tumors

Date:
January 25, 1999
Source:
Cedars-Sinai Medical Center
Summary:
Dendritic cell immunotherapy, a process that uses a vaccine derived from a patient's own cells to fight malignant cells, is being used to treat brain tumors at Cedars-Sinai Medical Center in Los Angeles. The clinical protocol is based on research done in the laboratory at Cedars-Sinai, and was used for the first time in patient treatment on May 11, 1998, at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute.

Los Angeles (January 21, 1999) -- Dendritic cell immunotherapy, a process that uses a vaccine derived from a patient's own cells to fight malignant cells, is being used to treat brain tumors at Cedars-Sinai Medical Center in Los Angeles. The clinical protocol is based on research done in the laboratory at Cedars-Sinai, and was used for the first time in patient treatment on May 11, 1998, at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute.

Related Articles


According to Keith Black, M.D., principal investigator on the project and one of eight physicians and scientists who have been researching dendritic cell immunotherapy, foreign proteins are taken from a tumor after surgical removal. These proteins are introduced to antigen presenting (or dendritic) cells taken from the patient's blood and grown in a Petri dish. The new dendritic cells, when re-injected into the patient, are intended to work like a vaccine, recognizing and destroying the lingering malignant tumor cells. Several such injections are typically scheduled over a six-week period.

Barbara Boyajian was among the first patients to undergo the experimental procedure, having been diagnosed in early June 1998 with glioblastoma multiforme, one of the most aggressive types of brain tumor. She first noticed a problem when her memory lost its sharpness. Shortly thereafter, she says, she walked into a wall. Thinking she needed glasses, she visited an eye doctor and he suggested she schedule an MRI. The malignant tumor was diagnosed and confirmed by three medical opinions. "I ended up in Dr. Black's hands, which was a blessing," says Boyajian.

Dr. Black and his team removed the tumor on July 23, 1998, and a six-week course of radiation therapy followed. Dendritic cell immunotherapy, initiated on Nov. 16, was completed on Dec. 30. Boyajian's positive outlook helped her get through a difficult time. She feels fine now and returns to the Neurosurgical Institute only for follow-up lab work and MRIs. "We're on this side of the tracks," she says, "and we're real excited about it and I have a lot of support from my family and my friends. And I have a tremendous amount of faith."

Dendritic cell immunotherapy has been approved by the Food & Drug Administration for Phase I study and has been used in treating other types of tumors. Other Cedars-Sinai Medical Center physicians and scientists involved in the research include: John Yu, M.D.; Christopher Wheeler, Ph.D.; Reid Thompson, M.D.; Brian Pikul, M.D.; Paul Zeltzer, M.D.; Divina Nacis, R.N.; and Mary Riedinger, R.N.


Story Source:

The above story is based on materials provided by Cedars-Sinai Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Cedars-Sinai Medical Center. "Dendritic Cell Immunotherapy May Provide Cancer Patients With A Vaccine To Combat Malignant Brain Tumors." ScienceDaily. ScienceDaily, 25 January 1999. <www.sciencedaily.com/releases/1999/01/990125073302.htm>.
Cedars-Sinai Medical Center. (1999, January 25). Dendritic Cell Immunotherapy May Provide Cancer Patients With A Vaccine To Combat Malignant Brain Tumors. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/1999/01/990125073302.htm
Cedars-Sinai Medical Center. "Dendritic Cell Immunotherapy May Provide Cancer Patients With A Vaccine To Combat Malignant Brain Tumors." ScienceDaily. www.sciencedaily.com/releases/1999/01/990125073302.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins